Dexlansoprazole Capsule, Delayed Release
Product Images NDC 72162-2244

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dexlansoprazole (NDC 72162-2244). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Dexlansoprazole Delayed Release Capsules 1)

Chemical structure of dexlansoprazole, showing its molecular arrangement including aromatic rings, sulfoxide group, and trifluoromethoxy substitution.*

FDA Label Image

Figure 1 (Dexlansoprazole Delayed Release Capsules 2)

A line graph showing plasma concentration (ng/mL) of dexlansoprazole over 24 hours. The graph compares 30 mg and 60 mg dosages. The 60 mg dose is represented by a solid line with circles, reaching higher concentrations than the 30 mg dose, shown with a dashed line with triangles. Concentrations peak between 2 to 4 hours and decline thereafter.*

FDA Label Image

Label (Lbl721622244)

Label for Dexlansoprazole Delayed-Release Capsules 30 mg, containing 30 capsules. The label lists Bryant Ranch Prepack, Inc. as the relabeler and Par Formulations Private Limited as the manufacturer. It includes storage instructions, a barcode, and the NDC 72162-2244-3.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.